Verity & Verity’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18M | Buy |
229,707
+11,197
| +5% | +$903K | 1.24% | 39 |
|
|
2026
Q1 | $18.9M | Buy |
218,510
+15,338
| +8% | +$1.47M | 1.41% | 33 |
|
|
2025
Q4 | $19.5M | Buy |
203,172
+4,598
| +2% | +$447K | 1.52% | 26 |
|
|
2025
Q3 | $18.9M | Buy |
198,574
+4,568
| +2% | +$420K | 1.51% | 27 |
|
|
2025
Q2 | $16.9M | Sell |
194,006
-2,193
| -1% | -$186K | 1.45% | 30 |
|
|
2025
Q1 | $17.6M | Buy |
196,199
+17,418
| +10% | +$1.56M | 1.55% | 30 |
|
|
2024
Q4 | $14.3M | Buy |
178,781
+2,683
| +2% | +$232K | 1.3% | 33 |
|
|
2024
Q3 | $15.9M | Buy |
176,098
+6,316
| +4% | +$531K | 1.55% | 27 |
|
|
2024
Q2 | $13.4M | Buy |
169,782
+4,036
| +2% | +$331K | 1.46% | 31 |
|
|
2024
Q1 | $14.4M | Sell |
165,746
-3,427
| -2% | -$292K | 1.61% | 24 |
|
|
2023
Q4 | $13.9M | Buy |
169,173
+38,091
| +29% | +$2.9M | 1.6% | 25 |
|
|
2023
Q3 | $10.3M | Buy |
131,082
+46,387
| +55% | +$3.88M | 1.29% | 35 |
|
|
2023
Q2 | $7.46M | Buy |
84,695
+11,231
| +15% | +$967K | 0.92% | 49 |
|
|
2023
Q1 | $5.92M | Buy |
73,464
+15,199
| +26% | +$1.24M | 0.76% | 54 |
|
|
2022
Q4 | $4.53M | Buy |
58,265
+4,024
| +7% | +$326K | 0.59% | 58 |
|
|
2022
Q3 | $4.38M | Buy |
54,241
+6,887
| +15% | +$619K | 0.71% | 54 |
|
|
2022
Q2 | $4.25M | Buy |
47,354
+2,857
| +6% | +$289K | 0.65% | 60 |
|
|
2022
Q1 | $4.94M | Buy |
44,497
+4,044
| +10% | +$427K | 0.68% | 56 |
|
|
2021
Q4 | $4.18M | Buy |
40,453
+1,582
| +4% | +$183K | 0.6% | 58 |
|
|
2021
Q3 | $4.71M | Buy |
38,871
+966
| +3% | +$125K | 0.7% | 54 |
|
|
2021
Q2 | $4.71M | Sell |
37,905
-13
| -0% | -$1.63K | 0.74% | 54 |
|
|
2021
Q1 | $4.67M | Buy |
37,918
+3,381
| +10% | +$396K | 0.76% | 54 |
|
|
2020
Q4 | $4.09M | Buy |
34,537
+6,143
| +22% | +$676K | 0.77% | 53 |
|
|
2020
Q3 | $2.94M | Buy |
28,394
+551
| +2% | +$55.3K | 0.65% | 58 |
|
|
2020
Q2 | $2.58M | Buy |
27,843
+2,005
| +8% | +$192K | 0.62% | 57 |
|
|
2020
Q1 | $2.33M | Sell |
25,838
-6,342
| -20% | -$675K | 0.66% | 54 |
|
|
2019
Q4 | $3.65M | Buy |
32,180
+932
| +3% | +$102K | 0.71% | 56 |
|
|
2019
Q3 | $3.34M | Buy |
31,248
+1,524
| +5% | +$159K | 0.71% | 55 |
|
|
2019
Q2 | $2.9M | Buy |
29,724
+12,870
| +76% | +$1.18M | 0.63% | 61 |
|
|
2019
Q1 | $1.53M | Buy |
+16,854
| New | +$1.51M | 0.35% | 75 |
|
Other funds holding MDT
Verity & Verity's MDT Position: Q2 2026 in Review
Verity & Verity increased its Medtronic (MDT) stake by 5.1% in Q2 2026, buying an estimated $903K and bringing the position to 229,707 shares worth $18M. The position accounts for 1.24% of the portfolio, ranked #39.
Verity & Verity first reported a position in MDT in Q1 2019 and has held it in 30 quarters since. The position peaked at $19.5M in Q4 2025. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Verity & Verity held 229,707 shares of Medtronic worth $18M as of Q2 2026.
- Verity & Verity bought 11,197 Medtronic shares in Q2 2026, an estimated $903K.
- Medtronic made up 1.24% of Verity & Verity's portfolio in Q2 2026, its #39 holding.
- Verity & Verity first reported a position in Medtronic in Q1 2019 and has held it in 30 quarters since.
- Verity & Verity's Medtronic position peaked at $19.5M in Q4 2025.
- 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Verity & Verity's 13F filing for Q2 2026, filed 28 Jul 2026.